ZBIO
ProShares UltraPro Short NASDAQ Biotechnology
ZBIO
ZBIO
Delisted
ZBIO was delisted on the 27th of March, 2020.
5 hedge funds and large institutions have $596K invested in ProShares UltraPro Short NASDAQ Biotechnology in 2019 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
–
Holders Change %
0%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$211K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
$33K |
| 3 |
UBS Group
Zurich,
Switzerland
|
$57K |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
$294K |
| 2 |
Morgan Stanley
New York
|
$1K |
| 3 |
CG
Cutler Group
San Francisco,
California
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $294K | -$64.6K | -3,834 | -18% |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $211K | +$41.2K | +2,449 | +24% |
|
|
3
UBS Group
Zurich,
Switzerland
| $57K | +$21.6K | +1,287 | +61% |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $33K | +$33K | +1,984 | New |
|
|
5
Morgan Stanley
New York
| $1K | -$15.3K | -931 | -94% |
|
|
CG
6
Cutler Group
San Francisco,
California
| – | -$5K | -399 | Closed |
|